The next generation endometrial receptivity testing solution for improving IVF treatment success.
MIRA is a first-in-class testing solution that uses novel microRNAs to successfuly increase pregnancy rate from 40% to 70%.
The next generation endometrial receptivity testing solution for improving IVF treatment success.
MIRA is a first-in-class testing solution that uses novel microRNAs to successfuly increase pregnancy rate from 40% to 70%.
OncoSweep utilizes breakthrough liquid biopsy method to detect cancer early, whilst it is still treatable. Through multi-omics approach using PanelChip as one of the tools, Pharus is able to determine risk of cancer to enable earlier disease management.
70% of patients with breast cancer are overtreated. Powered by PanelChip®, RecurIndex’s 28 mRNA biomarkers can assess recurrence risk for better treatment management.